Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04867850 · ClinicalTrials.gov registry record · NA
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 4,450
- Enrollment target
NCT04867850: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT04867850 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 4,450 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (217% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04867850, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,450 participants
- Enrollment target
Study Summary
The main purpose of this research study is to evaluate the effectiveness of "nudges" to clinicians, to patients, or to both in increasing Serious Illness Conversation (SIC) documentation; and to identify moderators of implementation effects on SIC documentation. The investigators will employ rapid-cycle approaches to optimize the framing of nudges to clinicians and patients prior to initiating the trial and mixed methods to explore contextual factors and mechanisms. The investigators will conduct a four-arm pragmatic cluster randomize clinical trial to test the effectiveness of nudges to clinicians, nudges to patients, or nudges to both in increasing the frequency and timeliness of SIC documentation in cancer patients vs. usual care (UC). The investigators hypothesize that each of the implementation strategy arms will significantly increase SIC documentation compared to UC and that the combination of nudges to clinicians and to patients will be the most effective.
Primary Outcome
Measured at the patient level as a binary outcome (yes/no) among high-risk patients based on date of documented note including the SIC template in the Advanced Care Planning (ACP) section of the electronic medical record by any provider Outcomes were measured for patients only.
Interventions
- OTHER Usual Care
- OTHER Clinician Nudge
- OTHER Patient Nudge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,450 participants |
| Start Date | 2021-09-09 |
| Est. Completion | 2022-09-09 |
| Phase | NA |
What the finished NCT04867850 record still lists
NCT04867850 is an interventional study that assigns participants to a tested intervention. Its 4,450 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (217% higher).
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT04867850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04867850 about?
NCT04867850 is a clinical study titled "Effect of Behavioral Nudges on Serious Illness Conversation Documentation". The main purpose of this research study is to evaluate the effectiveness of "nudges" to clinicians, to patients, or to both in increasing Serious Illness Conversation (SIC) documentation; and to identify moderators of implementation effects on SIC documentation. The investigators will employ rapid-c...
What is the current status of trial NCT04867850?
This trial is currently completed. It is a NA study. The enrollment target is 4,450 participants. The study started on 2021-09-09. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT04867850?
The interventions under investigation include: Usual Care (OTHER), Clinician Nudge (OTHER), Patient Nudge (OTHER).
Who is sponsoring clinical trial NCT04867850?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04867850's enrollment target sits among peer trials
4,450 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI